Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

NCT03135184 is registered in ClinicalTrials.gov with HDL Therapeutics as lead sponsor.

NCT NCT03135184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03135184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia
Lead sponsor
HDL Therapeutics
Phase
Not applicable
Overall status
Unknown status
Start date
January 26, 2018
Completion date
August 31, 2019
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hofh, homozygous familial hypercholesterolemia